General Information of Drug (ID: DMA4WEO)

Drug Name
ABSK021 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
139549388
TTD Drug ID
DMA4WEO

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pexidartinib DMS2J0Z Tenosynovial giant cell tumour 2F7B Approved [3]
Sulfatinib DMPOTM4 Neuroendocrine cancer 2B72.1 Phase 3 [4]
ARRY-382 DM0VGDC Solid tumour/cancer 2A00-2F9Z Phase 2 [4]
BLZ-945 DMG1LVA Amyotrophic lateral sclerosis 8B60.0 Phase 2 [4]
Cabiralizumab DMGE058 Pancreatic cancer 2C10 Phase 2 [5]
AMB-05X DM958C5 Idiopathic pulmonary fibrosis CB03.4 Phase 2 [6]
FPA-008 DM3ZN6Y Autoimmune diabetes 5A10 Phase 1/2 [7]
DCC-3014 DMHW289 Solid tumour/cancer 2A00-2F9Z Phase 1/2 [4]
DCC-3014 DMHW289 Solid tumour/cancer 2A00-2F9Z Phase 1/2 [8]
PLX7486 DM0IVGU Pancreatic cancer 2C10 Phase 1 [4]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Macrophage colony-stimulating factor 1 receptor (CSF1R) TT7MRDV CSF1R_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT04192344) A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK021 in Patients With Advanced Solid Tumor. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Abbisko Therapeutics.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 Clinical pipeline report, company report or official report of AmMax Bio
7 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
8 Clinical pipeline report, company report or official report of Deciphera Pharmaceuticals.